Ionis Pharmaceuticals, Inc. - 企業プロファイルおよびSWOT分析Ionis Pharmaceuticals, Inc. - Company Profile and SWOT Analysis Ionis Pharmaceuticals, Inc. - 企業プロファイルおよびSWOT分析 概要 Ionis Pharmaceuticals, Inc. - 企業プロファイルおよびSWOT分析は、包括的な企業データおよび情報源です。本レポートは、同社の組織... もっと見る
サマリーIonis Pharmaceuticals, Inc. - 企業プロファイルおよびSWOT分析概要 Ionis Pharmaceuticals, Inc. - 企業プロファイルおよびSWOT分析は、包括的な企業データおよび情報源です。本レポートは、同社の組織構造、事業運営、SWOT分析、製品・サービス提供、および企業活動を網羅し、同社の360度の全体像を提供します。 主なハイライト Ionis Pharmaceuticals, Inc.(Ionis)は、リボ核酸(RNA)を標的とした治療薬の発見および開発を行っています。同社の主要製品には、TRYNGOLZA、WAINUA、SPINRAZA、QALSODY、TEGSEDI、WAYLIVRAがあり、家族性カイロミクロン血症症候群、遺伝性トランスサイレチン型アミロイドーシス、脊髄性筋萎縮症、筋萎縮性側索硬化症などの治療に使用されています。同社は独自のアンチセンス技術に基づいて製品を開発しています。IonisはAstraZenecaやBiogenなどのチャネルパートナーと協力し、製品の開発および商業化を進めています。また、現在さまざまな臨床試験段階にある一連の製品も含まれています。同社は複数の地域で事業を展開しており、米国、欧州、その他の地域を市場としています。同社は米国カリフォルニア州カールスバッドに本社を置いています。 本レポートの対象範囲 - 事業戦略および競合インテリジェンスに必要なIonis Pharmaceuticals, Inc.に関する詳細情報 - SWOT分析の形式による、Ionis Pharmaceuticals, Inc.に影響を与える主要な内部要因および外部要因の分析 - 主要事業セグメントの内訳と検証を含む、Ionis Pharmaceuticals, Inc.のビジネスモデルの詳細な分析 - Ionis Pharmaceuticals, Inc.のM&A(合併・買収)、戦略的パートナーシップおよび提携、資金調達、プライベートエクイティ取引、財務・法務アドバイザーに関するインテリジェンス - 事業拡大、再編、契約獲得など、Ionis Pharmaceuticals, Inc.に関するニュース - 重要なデータや主要トレンドを示す、分かりやすい図表・グラフを豊富に掲載 本レポートを購入する理由 - Ionis Pharmaceuticals, Inc.およびその戦略に影響を与える要因について理解を深めることができます。 - 同社の戦略的取り組みや最新の企業ニュース・動向を追跡できます。 - Ionis Pharmaceuticals, Inc.を将来的なパートナー、ベンダー、またはサプライヤーとして評価できます。 - 顧客企業のビジネスをより深く理解することで、営業活動を支援します。 - Ionis Pharmaceuticals, Inc.の事業構造、戦略、今後の見通しについて最新情報を把握できます。 目次Table of ContentsCompany Snapshot Ionis Pharmaceuticals, Inc.: Company Overview Ionis Pharmaceuticals, Inc.: Overview and Key Facts Ionis Pharmaceuticals, Inc.: Overview Ionis Pharmaceuticals, Inc.: Key Facts Ionis Pharmaceuticals, Inc.: Key Employees Ionis Pharmaceuticals, Inc.: Key Employee Biographies Ionis Pharmaceuticals, Inc.: Major Products and Services Ionis Pharmaceuticals, Inc.: Management Statement Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries Ionis Pharmaceuticals, Inc.: Key Competitors Ionis Pharmaceuticals, Inc.: Company Analysis Ionis Pharmaceuticals, Inc.: Business Description Ionis Pharmaceuticals, Inc.: SWOT Analysis Ionis Pharmaceuticals, Inc.: SWOT Overview Ionis Pharmaceuticals, Inc.: Strengths Ionis Pharmaceuticals, Inc.: Weaknesses Ionis Pharmaceuticals, Inc.: Opportunities Ionis Pharmaceuticals, Inc.: Threats Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity Ionis Pharmaceuticals, Inc.: Financial Deals Overview Ionis Pharmaceuticals, Inc.: Targets and Partners Ionis Pharmaceuticals, Inc.: Top Deals 2022 - 2026YTD* Ionis Pharmaceuticals, Inc.: Advisors Ionis Pharmaceuticals, Inc.: Top Legal Advisors Ionis Pharmaceuticals, Inc.: Top Financial Advisors Ionis Pharmaceuticals, Inc.: Capital Raising Ionis Pharmaceuticals, Inc.: Partnership Ionis Pharmaceuticals, Inc.: Divestments Ionis Pharmaceuticals, Inc.: Recent Developments Ionis Pharmaceuticals, Inc.: News and Events Summary Ionis Pharmaceuticals, Inc.: Corporate Governance Ionis Pharmaceuticals, Inc.: Corporate Social Responsibility Ionis Pharmaceuticals, Inc.: Financial Performance Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events Ionis Pharmaceuticals, Inc.: Research & Development Ionis Pharmaceuticals, Inc.: Strategy and Operations Appendix Contact Us Methodology About MarketLine 図表リストList of TablesTable 1: Ionis Pharmaceuticals, Inc.: Key Facts Table 2: Ionis Pharmaceuticals, Inc.: Key Employees Table 3: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries Table 4: Ionis Pharmaceuticals, Inc.: Key Competitors Table 5: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*) Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026) Table 7: Ionis Pharmaceuticals, Inc.: Targets and Partners Table 8: Ionis Pharmaceuticals, Inc.: Top Deals 2022 - 2026YTD* Table 9: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m) Table 10: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m) Table 11: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026) Table 12: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2022 - YTD*2026) Table 13: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026) Table 14: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026) Table 15: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026) Table 16: Ionis Pharmaceuticals, Inc.: News and Events Summary Table 17: Ionis Pharmaceuticals, Inc.: Corporate Governance Table 18: Ionis Pharmaceuticals, Inc.: Corporate Social Responsibility Table 19: Ionis Pharmaceuticals, Inc.: Financial Performance Table 20: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events Table 21: Ionis Pharmaceuticals, Inc.: Research & Development Table 22: Ionis Pharmaceuticals, Inc.: Strategy and OperationsList of Figures Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*) Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026) Figure 3: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026) Figure 4: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2022 - YTD*2026) Figure 5: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026) Figure 6: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026) Figure 7: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
SummaryIonis Pharmaceuticals, Inc. - Company Profile and SWOT AnalysisSummary Ionis Pharmaceuticals, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Ionis Pharmaceuticals, Inc. (Ionis) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company's major products include TRYNGOLZA, WAINUA, SPINRAZA, QALSODY, TEGSEDI, and WAYLIVRA, which are used to treat conditions such as familial chylomicronemia syndrome, hereditary transthyretin-mediated amyloidosis, spinal muscular atrophy, and amyotrophic lateral sclerosis. It develops products based on its proprietary antisense technology. Ionis collaborates with channel partners such as AstraZeneca and Biogen for the development and commercialization of its products. It also includes a series of products that are currently in various phases of clinical trials. The company operates in various geographic locations, targeting markets in the US, Europe, and other regions. The company is headquartered in Carlsbad, California, the US Scope - Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis - An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments - Intelligence on Ionis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Reasons to Buy - Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies. - Track strategic initiatives of the company and latest corporate news and actions. - Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier. - Support sales activities by understanding your customers' businesses better. - Stay up to date on Ionis Pharmaceuticals, Inc.'s business structure, strategy and prospects. Table of ContentsTable of ContentsCompany Snapshot Ionis Pharmaceuticals, Inc.: Company Overview Ionis Pharmaceuticals, Inc.: Overview and Key Facts Ionis Pharmaceuticals, Inc.: Overview Ionis Pharmaceuticals, Inc.: Key Facts Ionis Pharmaceuticals, Inc.: Key Employees Ionis Pharmaceuticals, Inc.: Key Employee Biographies Ionis Pharmaceuticals, Inc.: Major Products and Services Ionis Pharmaceuticals, Inc.: Management Statement Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries Ionis Pharmaceuticals, Inc.: Key Competitors Ionis Pharmaceuticals, Inc.: Company Analysis Ionis Pharmaceuticals, Inc.: Business Description Ionis Pharmaceuticals, Inc.: SWOT Analysis Ionis Pharmaceuticals, Inc.: SWOT Overview Ionis Pharmaceuticals, Inc.: Strengths Ionis Pharmaceuticals, Inc.: Weaknesses Ionis Pharmaceuticals, Inc.: Opportunities Ionis Pharmaceuticals, Inc.: Threats Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity Ionis Pharmaceuticals, Inc.: Financial Deals Overview Ionis Pharmaceuticals, Inc.: Targets and Partners Ionis Pharmaceuticals, Inc.: Top Deals 2022 - 2026YTD* Ionis Pharmaceuticals, Inc.: Advisors Ionis Pharmaceuticals, Inc.: Top Legal Advisors Ionis Pharmaceuticals, Inc.: Top Financial Advisors Ionis Pharmaceuticals, Inc.: Capital Raising Ionis Pharmaceuticals, Inc.: Partnership Ionis Pharmaceuticals, Inc.: Divestments Ionis Pharmaceuticals, Inc.: Recent Developments Ionis Pharmaceuticals, Inc.: News and Events Summary Ionis Pharmaceuticals, Inc.: Corporate Governance Ionis Pharmaceuticals, Inc.: Corporate Social Responsibility Ionis Pharmaceuticals, Inc.: Financial Performance Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events Ionis Pharmaceuticals, Inc.: Research & Development Ionis Pharmaceuticals, Inc.: Strategy and Operations Appendix Contact Us Methodology About MarketLine List of Tables/GraphsList of TablesTable 1: Ionis Pharmaceuticals, Inc.: Key Facts Table 2: Ionis Pharmaceuticals, Inc.: Key Employees Table 3: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries Table 4: Ionis Pharmaceuticals, Inc.: Key Competitors Table 5: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*) Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026) Table 7: Ionis Pharmaceuticals, Inc.: Targets and Partners Table 8: Ionis Pharmaceuticals, Inc.: Top Deals 2022 - 2026YTD* Table 9: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m) Table 10: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m) Table 11: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026) Table 12: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2022 - YTD*2026) Table 13: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026) Table 14: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026) Table 15: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026) Table 16: Ionis Pharmaceuticals, Inc.: News and Events Summary Table 17: Ionis Pharmaceuticals, Inc.: Corporate Governance Table 18: Ionis Pharmaceuticals, Inc.: Corporate Social Responsibility Table 19: Ionis Pharmaceuticals, Inc.: Financial Performance Table 20: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events Table 21: Ionis Pharmaceuticals, Inc.: Research & Development Table 22: Ionis Pharmaceuticals, Inc.: Strategy and OperationsList of Figures Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*) Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026) Figure 3: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026) Figure 4: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2022 - YTD*2026) Figure 5: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026) Figure 6: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026) Figure 7: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
MarketLine社の Pharmaceuticals and Healthcare分野 での最新刊レポート
よくあるご質問MarketLine社はどのような調査会社ですか?マーケットライン(MarketLine)は、世界の企業を幅広く対象に様々な角度から調査した企業レポートも出版しています。 マーケットライン(MarketLine)はGlobalDataの... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|